Control of hypertension and reversal of renal failure in undifferentiated connective tissue disease by enalapril.
Activation of the renin angiotensin system is important in the development of accelerated hypertension and progression to acute renal failure in scleroderma and undifferentiated connective tissue disease. Inhibition of angiotensin-converting enzyme activity may effectively control blood pressure and ameliorate renal insufficiency. To our knowledge, we describe the first reversal of dialysis-dependent renal insufficiency by enalapril maleate and recovery and maintenance of near-normal renal function in a patient suffering from undifferentiated connective tissue disease with sclerodermatous features. The pathophysiologic mechanisms and long-term treatment implications with angiotensin-converting enzyme inhibitors in this setting are discussed.
Strongwater
S L
SL
Department of Medicine, University of Massachusetts Medical Center, Worcester 01655-2397.
Galvanek
E G
EG
Stoff
J S
JS
D058186:Acute Kidney Injury / Q000188:drug therapy* / Q000209:etiology; D000328:Adult; D002216:Captopril / Q000009:adverse effects / Q000627:therapeutic use; D003240:Connective Tissue Diseases / Q000150:complications*; D004656:Enalapril / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D012084:Renin-Angiotensin System
D004656:Enalapril; D002216:Captopril